Obagi has developed clinically-proven skin health products and systems primarily for the dermatology, plastic surgery and related aesthetic markets. Using its Penetrating Therapeutics™ technologies, the company’s products are designed to improve penetration of prescription and cosmetic agents across the skin barrier for common and visible skin conditions in adult skin including premature aging, photodamage, hyperpigmentation (irregular or patchy discoloration of the skin), acne, sun damage, rosacea and soft tissue deficits, such as fine lines and wrinkles. The Obagi Nu-Derm System consists of topical products, which when used as a system result in substantial improvement to many of these skin related conditions. The company continues to maintain its position as a leader in skin health by having launched several successful new systems of products, including the Obagi-C® Rx System which is the first prescription-strength Vitamin C and hydroquinone system; the Condition & Enhance™ System, developed to enhance the results of physician delivered surgical and non-surgical procedures; the ELASTIderm® family of products, a one of a kind treatment developed to restore skin elasticity and collagen production, and reduce fine lines and wrinkles around the eyes and décolletage; CLENZIderm M.D.™ Acne Therapeutic Systems to treat and prevent acne at it’s root; and most recently the Rosaclear™ System, developed specifically for the treatment and prevention of the signs and symptoms of rosacea.